title: Occurrence of the same chromosome abnormalities in Ph+ and Ph- cells in chronic myeloid leukaemia. Evidence of a secondary origin of the Ph chromosome?
authors.forename: Emilio
authors.initials: E
authors.lastname: Donti
authors.forename: Alfonso
authors.initials: A
authors.lastname: Zaccaria
authors.forename: Alessandra
authors.initials: A
authors.lastname: Bassetti
authors.forename: Giovanna
authors.initials: G
authors.lastname: Venti
authors.forename: Barbara
authors.initials: B
authors.lastname: Giannini
authors.forename: Paolo
authors.initials: P
authors.lastname: Prontera
authors.forename: Erika
authors.initials: E
authors.lastname: Bianchi
authors.forename: Anna
authors.initials: A
authors.lastname: Valenti
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Saglio
authors.forename: Anna Marina
authors.initials: AM
authors.lastname: Liberati
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D001549:Benzamides; D002869:Chromosome Aberrations / Q000139:chemically induced*; D017809:Fatal Outcome; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics*; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000009:adverse effects; D011743:Pyrimidines / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate